Table 4.

Joint effects of sTREM2 and galectin-3 on the risk of study outcomes after acute ischemic stroke

Analyses based on a sample restricted to individuals with both sTREM2 and galectin-3 values (n = 2808)

sTREM2 soluble triggering receptor expressed on myeloid cells 2, HR hazard ratio, OR odds ratio, CI confidence interval

^†sTREM2 and galectin-3 were classified into two categories (high versus low) based on the 75th percentile

HR or OR was adjusted for age, sex, current smoking, alcohol drinking, time from onset to randomization, admission NIHSS score, systolic blood pressure, high-sensitivity C-reactive protein, history of hypertension, hyperlipidemia, coronary heart disease, and diabetes mellitus, use of antihypertensive and lipid-lowering medications, family history of stroke, stroke subtype and randomized treatment